Last reviewed · How we verify

NCT04971603

The Effectiveness and Safety of Acupuncture for Elderly Patients of Stroke

Status unknown NA Last updated 21 July 2021
What this trial tests

NA trial testing Acupuncture in Stroke in 500 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
31 December 2023
31 January 2024

Quick facts

Lead sponsorHong Kong Baptist University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment500
Start date1 January 2021
Primary completion31 December 2023
Estimated completion31 January 2024
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Hong Kong Baptist University

Who can join

Adults 35 to 95, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke and its sequelae are a major indication for acupuncture. The specific aims of this study are to assess the feasibility of pragmatic clinical trial on acupuncture in primary care setting and evaluate the effectiveness and safety of acupuncture for stroke rehabilitation in Hong Kong.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hong Kong Baptist University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04971603.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing